Home

Adline Chem Lab Ltd PE Ratio

Image

Adline Chem Lab Ltd

NSE: ADLINECHEMLAB

PE

-

Last updated on: Jan 22, 2025

Key Highlights

  • The P/E Ratio of Adline Chem Lab Ltd is 0 as of 22 Jan 09:09 AM .
  • The P/E Ratio of Adline Chem Lab Ltd changed from 5.3 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Latest Trading Price of Adline Chem Lab Ltd is ₹ 19.1 as of 20 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Adline Chem Lab Ltd

No data available

Company Fundamentals for Adline Chem Lab Ltd

Image

Adline Chem Lab Ltd

NSE: ADLINECHEMLAB

Share Price

₹ 19.1

-0.99 (-4.93%)

stock direction

Last updated on: Jan 20, 2025

Market Price of Adline Chem Lab Ltd

1M

1Y

3Y

5Y

Monitoring Adline Chem Lab Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Jan 202519.1
13 Jan 202520.09
06 Jan 202521.14
30 Dec 202422.25
13 Dec 202422.25
12 Dec 202421.2
11 Dec 202420.2
10 Dec 202419.25
09 Dec 202419.99
06 Dec 202420.25

SWOT Analysis Of Adline Chem Lab Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Adline Chem Lab Ltd

Asset Value vs Market Value of Adline Chem Lab Ltd

Market Value

₹ 0

Asset Value

₹ 0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Adline Chem Lab Ltd11.17
Sun Pharmaceuticals Industries Ltd422715
Cipla Ltd115271
Dr Reddys Laboratories Ltd107511
Mankind Pharma Ltd105755

PE Ratio of Adline Chem Lab Ltd Explained

``
Created with Highcharts 11.4.1Share PriceBook value​per share

₹11.17

Market cap

₹0

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

Created with Highcharts 11.4.1212528.227.140PE Ratio of Pharmaceuticals Industry over time20202021202220232024

PE Ratio of Top Sectors

Created with Highcharts 11.4.120.317.830.440157.636.9PE Ratio of Top SectorsAutomobileFinanceIT - SoftwarePharmaceuticalsRetailTextiles

Historical Market Cap of Adline Chem Lab Ltd

No data available

* All values are in ₹ crore

Historical Revenue, EBITDA and Net Profit of Adline Chem Lab Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in ₹ crore

Historical Dividend Payout of Adline Chem Lab Ltd

No data available

* All values are in %

About Adline Chem Lab Ltd

  • Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari.
  • The Company name was changed from Kamron Laboratories Limited' to Adline Chem Lab Limited effective on October 13, 2021. The Company is engaged primarily in the business of marketing of Pharmaceutical and Nutraceuticals products. In May 1990, the Company started production at its site in Rakanpur, Gujarat.
  • Initially, the Company was manufacturing tablets, capsules and liquid orals.
  • In 1993, it started manufacture of injections. At present, the company is marketing its products in many states of India and also exporting to a few countries.
  • But over the period of last three decades, there were major changes in the manufacturing technology and building layout due to which the company's plant became obsolete.

Adline Chem Lab Ltd News Hub

Adline Chem Lab to hold board meeting

Adline Chem Lab will hold a meeting of the Board of Directors of the Company on 24 August 2024. Powe

Read more

17 Aug 2024

Adline Chem Lab to convene AGM

Adline Chem Lab announced that the 36th Annual General Meeting (AGM) of the company will be held on

Read more

28 Aug 2024

Adline Chem Lab to conduct board meeting

Adline Chem Lab will hold a meeting of the Board of Directors of the Company on 29 October 2024. Pow

Read more

23 Oct 2024

Adline Chem Lab revises board meeting date

Adline Chem Lab has revised the meeting of the Board of Directors which was scheduled to be held on

Read more

29 Oct 2024

Product Composition by Percentage (Revenue)

Created with Highcharts 11.4.1

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Adline Chem Lab Ltd

What is the current PE Ratio of Adline Chem Lab Ltd?

The Current PE Ratio of Adline Chem Lab Ltd is 0.0 as on 22 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Jan 2025.

What was the PE Ratio of Adline Chem Lab Ltd last year?

The PE Ratio of Adline Chem Lab Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Adline Chem Lab Ltd indicate about its stock?

The PE Ratio of Adline Chem Lab Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Adline Chem Lab Ltd.

What is the PE Ratio Growth of Adline Chem Lab Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Adline Chem Lab Ltd grew by -% whereas, the EPS ratio grew by -0.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions